SOURCE: Holzer Holzer & Fistel, LLC

Holzer Holzer & Fistel, LLC

April 15, 2013 12:12 ET

Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Family Dollar Stores, Inc. and Incyte Corporation

ATLANTA, GA--(Marketwired - Apr 15, 2013) -  Holzer Holzer & Fistel LLC reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Family Dollar Stores, Inc. (FDO) and Incyte Corporation (INCY).

Investors that suffered significant losses investing in either of these companies during the specified times who are interested in potentially serving as lead plaintiff in the respective class actions are encouraged to contact Michael I. Fistel, Jr., Esq. (mfistel@holzerlaw.com) or Marshall P. Dees, Esq. (mdees@holzerlaw.com) by email or via toll-free telephone at (888) 508-6832 to discuss their legal rights.

Family Dollar Stores, Inc.

A class action lawsuit has been filed on behalf of investors who purchased Family Dollar (NYSE: FDO) common stock between October 3, 2012 and January 2, 2013. The lawsuit alleges the company violated the federal securities laws by, among other things, failing to adequately disclose softening demand for its higher-end discretionary items compared to its lower margin consumables which, according to the complaint, resulted in lower profits and a buildup of merchandise that negatively impacts profitability.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Western District of North Carolina, is April 22, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Incyte Corporation

A class action lawsuit has been filed on behalf of investors who purchased Incyte (NASDAQ: INCY) common stock between April 26, 2012 and August 1, 2012, inclusive, alleging the company violated the federal securities laws by making false and misleading statements to investors regarding, among other things, demand for its drug Jakafi (ruxolitinib).

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the District of Delaware, is May 6, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

About The Firm

Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.